Squarepoint
STRO icon

Squarepoint’s Sutro Biopharma STRO Stock Holding History

Squarepoint’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
+55,539
New +$1.73M ﹤0.01% 2406
2024
Q4 		– Sell
-4,971
Closed -$172K – 5479
2024
Q3 		$172K Buy
4,971
+1,052
+27% +$41.2K ﹤0.01% 3741
2024
Q2 		$115K Buy
+3,919
New +$155K ﹤0.01% 3770
2024
Q1 		– Sell
-1,390
Closed -$59.6K – 4590
2023
Q4 		$59.6K Buy
+1,390
New +$44.1K ﹤0.01% 3832
2023
Q2 		– Sell
-1,295
Closed -$59.8K – 3996
2023
Q1 		$59.8K Buy
+1,295
New +$82.2K ﹤0.01% 3033
2022
Q3 		– Sell
-3,404
Closed -$177K – 3418
2022
Q2 		$177K Sell
3,404
-768
-18% -$42.9K ﹤0.01% 2509
2022
Q1 		$343K Buy
4,172
+392
+10% +$37.3K ﹤0.01% 2199
2021
Q4 		$562K Buy
3,780
+2,657
+237% +$476K ﹤0.01% 2066
2021
Q3 		$212K Sell
1,123
-2,365
-68% -$450K ﹤0.01% 2453
2021
Q2 		$648K Buy
+3,488
New +$683K ﹤0.01% 1956
2020
Q4 		– Sell
-2,866
Closed -$288K – 3248
2020
Q3 		$288K Sell
2,866
-132
-4% -$12.5K ﹤0.01% 1830
2020
Q2 		$233K Sell
2,998
-939
-24% -$90.1K ﹤0.01% 1751
2020
Q1 		$402K Buy
3,937
+1,155
+42% +$121K 0.01% 1153
2019
Q4 		$306K Buy
2,782
+687
+33% +$70.8K ﹤0.01% 2028
2019
Q3 		$190K Buy
2,095
+845
+68% +$85.3K ﹤0.01% 2096
2019
Q2 		$142K Buy
+1,250
New +$138K ﹤0.01% 2169

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Squarepoint's STRO Position: Q2 2026 in Review

Squarepoint opened a new position in Sutro Biopharma (STRO) in Q2 2026: 55,539 shares worth $1.84M. The stake represents ﹤0.01% of the portfolio and ranks #2406 among its holdings. This is a return to the name: Squarepoint previously reported a position in STRO as recently as Q3 2024.

Squarepoint first reported a position in STRO in Q2 2019 and has held it in 16 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Squarepoint held 55,539 shares of Sutro Biopharma worth $1.84M as of Q2 2026.
  • Sutro Biopharma was a new Squarepoint position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2406 holding.
  • Squarepoint first reported a position in Sutro Biopharma in Q2 2019 and has held it in 16 quarters since.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.